Cyclic CRF agonists

Chemistry: natural resins or derivatives; peptides or proteins; – Peptides of 3 to 100 amino acid residues – Corticotropin ; related peptides

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

530317, 930 21, 930 70, 930260, 514 9, 514 2, 514805, A61K 3828, A61K 3812, C07K 14695, C07K 764

Patent

active

058440747

ABSTRACT:
Novel cyclic CRF agonist peptides have the amino acid sequence: (cyclo 30-33)Ac-Pro-Pro-Ile-Ser-Leu-Asp-Leu-Thr-D-Phe-His-Leu-Leu-Arg-Glu-Val-Leu -Glu-Nle-Ala-Arg-Ala-Glu-Gln-Leu-Ala-Gln-R.sub.30 -Ala-R.sub.32 -R.sub.33 -Asn-Arg-Lys-Leu-Nle-Glu-Ile-Ile-NH.sub.2 wherein R.sub.30 is Glu or Cys; R.sub.32 is His or a D-amino acid such as D-His, D-Arg or similar; R.sub.33 is Lys, Orn or Cys. The N-terminus may be extended by Ser-Glu-Glu. Lys may be substituted for Arg.sup.23, and its side chain connected by a lactam bridge to Glu.sup.20 to form a bicyclic peptide. Certain disclosed CRF agonists include: Glu.sup.30, Lys.sup.33 !r/hCRF(4-41), Glu.sup.30, Orn.sup.33 !r/hCRF(4-41), D-His.sup.32 !r/hCRF(4-41), Lys.sup.23,33, Glu.sup.30, D-His.sup.32 !-r/hCRF(4-41), Glu.sup.30, imBzlD-His.sup.32, Lys.sup.33 !r/hCRF(4-41) and D-Arg.sup.32, Lys.sup.33 !r/hCRF(4-41). Nle.sup.21,38, Glu.sup.30, D-His.sup.32, Lys.sup.33 !r/hCRF and (cyclo D-His.sup.32, Lys.sup.33 !r/hCRF(3-41) are useful in screening for more potent agonists.

REFERENCES:
patent: 5439885 (1995-08-01), Kornreich et al.
patent: 5493006 (1996-02-01), de Miranda et al.
Gulyas et al., "Potent, structurally constrained agonists and competitive antagonists of corticotropin-releasing factor", P.N.A.S., vol. 92, pp. 10575-10579 (Nov. 1995).
Miranda, A. et al. Conformationally restricted competitive a factor. J. Med. Chem. 37, 1450-1459, Oct. 1994.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Cyclic CRF agonists does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Cyclic CRF agonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cyclic CRF agonists will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-2396544

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.